Alzheimer's is a common form of dementia (senility) affecting almost 5 million Americans. As our population ages, this is an area that drug companies believe may be quite profitable, so there is heavy advertising being done for the medication...
The pharmaceutical companies have spectacularly failed to move beyond the 'chemical imbalance' view of Alzheimer's disease. But new evidence points to brain poisoning-by processed foods and heavy metals-as likely causes, and many alternatives offer...
BAD SCIENCE So many studies, so many flaws A full one-third of American scientists have been found guilty of serious misconduct while undertaking medical research over the last three years. Their misdeeds have included the falsification of data...
Drug companies have been accused of suppressing vital data showing that their new-generation atypical antipsychotics are killing around one in four elderly dementia patients. The startling discovery was made in nine separate studies that were...
Levodopa’s ability to reduce the distressing symptoms of early-stage Parkinson’s disease has earned itself enough street cred to become the first-line treatment for the condition. However, there’s a flip-side to every coin, and this drug is no...
Risperdal (risperidone) is the most prescribed antipsychotic in the US and, with worldwide sales of $2.1bn, is Johnson & Johnson’s second most profitable drug.
Open warfare is breaking out in the medical research industry over the cause of Alzheimer's, the most common form of senile dementia. ...
Cook with olive oil and you could ward off depression and dementia. The two new studies that make the discoveries add to the mounting evidence that a diet high in fatty acids is good for you afte ...
Dietary intake of antioxidants, particularly vitamins C and E, may lower the risk of developing Alzheimer’s, according to recent evidence.
The maverick practice of off-label prescribing - giving drugs for unapproved conditions/patients - is once again in the limelight. The US Food and Drug Administration (FDA) has issued a warning against using ‘atypical antipsychotics’ to treat...